Stereotaxis share price today

(STXS)

Stereotaxis share price is $2.24 & ₹190.01 as on 12 Dec 2024, 2.30 'hrs' IST

$2.24

▲

0.07

(3.23%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Stereotaxis share price in Dollar and Rupees. Guide to invest in Stereotaxis from India. Also see the sentimental analysis on Indian investors investing in Stereotaxis. Get details on the Indian mutual funds that are investing in Stereotaxis. Get Analyst recommendations and forecasts along with all the Stereotaxis's financials.

Stereotaxis share price movements

$2.17
$2.28
$2.24
3.35%
Downside
Day's Volatility :4.84%
Upside
1.54%
$1.63
$3.29
$2.24
27.23%
Downside
52 Weeks Volatility :50.46%
Upside
31.91%

Stereotaxis Returns

Period	Stereotaxis Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-1.36%	-7.2%	0.0%
6 Months	13.61%	-1.5%	0.0%
1 Year	24.71%	8.4%	0.0%
3 Years	-63.03%	7.1%	-20.0%

Stereotaxis Key Statistics

in dollars & INR

Previous Close	$2.17
Open	$2.21
Today's High	$2.275
Today's Low	$2.165
Market Capitalization	$186.4M
Today's Volume	$236.6K
52 Week High	$3.29
52 Week Low	$1.63
Revenue TTM	$25.1M
EBITDA	$-21.9M
Earnings Per Share (EPS)	$-0.27
Profit Margin	-85.79%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-106.46%

How to invest in Stereotaxis from India?

It is very easy for Indian residents to invest directly in Stereotaxis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Stereotaxis stock in both rupees (INR) and dollars (USD). Search for Stereotaxis or STXS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Stereotaxis or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Stereotaxis shares which would translate to 0.379 fractional shares of Stereotaxis as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Stereotaxis

71%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Stereotaxis on INDmoney from India has grown in the last 30 days as on Dec 12, 2024. 71% more investors are searching Stereotaxis in the last 30 days versus the previous period.

Analyst Recommendation on Stereotaxis

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Stereotaxis(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Stereotaxis

What analysts predicted

Upside of 100.89%

Current:

$2.24

Target:

$4.50

Insights on Stereotaxis

Price Movement
In the last 1 month, STXS stock has moved up by 17.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 4.50M → 9.19M (in $), with an average increase of 51.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -4.50M → -6.19M (in $), with an average decrease of 17.8% per quarter
STXS vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 70.6% return, outperforming this stock by 51.4%
STXS vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 56.0% return, outperforming this stock by 120.5%
Price to Sales
ForSTXS every $1 of sales, investors are willing to pay $7.3, whereas for Intuitive Surgical, Inc., the investors are paying $24.2 for every $1 of sales.

Stereotaxis Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$29.3M	↓ 5.77%
Net Income	$116.8K	↓ 101.98%
Net Profit Margin	0.4%	↑ 19.3%

	FY19	Y/Y Change
Revenue	$28.9M	↓ 1.51%
Net Income	$-4.2M	↓ 3725.49%
Net Profit Margin	-14.65%	↓ 15.05%

	FY20	Y/Y Change
Revenue	$26.6M	↓ 7.86%
Net Income	$-6.5M	↑ 52.44%
Net Profit Margin	-24.23%	↓ 9.58%

	FY21	Y/Y Change
Revenue	$35.0M	↑ 31.51%
Net Income	$-8.4M	↑ 30.75%
Net Profit Margin	-24.09%	↑ 0.14%

	FY22	Y/Y Change
Revenue	$28.1M	↓ 19.63%
Net Income	$-19.2M	↑ 126.98%
Net Profit Margin	-68.04%	↓ 43.95%

	FY23	Y/Y Change
Revenue	$26.8M	↓ 4.89%
Net Income	$-20.7M	↑ 8.16%
Net Profit Margin	-77.37%	↓ 9.33%

	Q2 FY23	Q/Q Change
Revenue	$7.9M	↑ 20.02%
Net Income	$-5.0M	↑ 0.85%
Net Profit Margin	-63.07%	↑ 11.99%

	Q3 FY23	Q/Q Change
Revenue	$7.8M	↓ 0.76%
Net Income	$-5.7M	↑ 15.13%
Net Profit Margin	-73.18%	↓ 10.11%

	Q4 FY23	Q/Q Change
Revenue	$4.6M	↓ 41.47%
Net Income	$-5.0M	↓ 11.69%
Net Profit Margin	-110.41%	↓ 37.23%

	Q1 FY24	Q/Q Change
Revenue	$6.9M	↑ 50.71%
Net Income	$-4.5M	↓ 10.58%
Net Profit Margin	-65.51%	↑ 44.9%

	Q2 FY24	Q/Q Change
Revenue	$4.5M	↓ 34.56%
Net Income	$-5.8M	↑ 29.42%
Net Profit Margin	-129.56%	↓ 64.05%

	Q3 FY24	Q/Q Change
Revenue	$9.2M	↑ 104.26%
Net Income	$-6.2M	↑ 6.12%
Net Profit Margin	-67.31%	↑ 62.25%

	FY18	Y/Y Change
Total Assets	$18.5M	↑ 73.57%
Total Liabilities	$11.2M	↓ 64.05%

	FY19	Y/Y Change
Total Assets	$43.6M	↑ 135.41%
Total Liabilities	$15.1M	↑ 33.95%

	FY20	Y/Y Change
Total Assets	$55.5M	↑ 27.24%
Total Liabilities	$15.2M	↑ 1.11%

	FY21	Y/Y Change
Total Assets	$61.0M	↑ 9.97%
Total Liabilities	$21.6M	↑ 41.6%

	FY22	Y/Y Change
Total Assets	$53.4M	↓ 12.42%
Total Liabilities	$21.5M	↓ 0.36%

	FY23	Y/Y Change
Total Assets	$41.9M	↓ 21.54%
Total Liabilities	$20.0M	↓ 6.96%

	Q2 FY23	Q/Q Change
Total Assets	$48.3M	↓ 4.72%
Total Liabilities	$21.3M	↓ 0.34%

	Q3 FY23	Q/Q Change
Total Assets	$44.5M	↓ 7.84%
Total Liabilities	$20.2M	↓ 5.23%

	Q4 FY23	Q/Q Change
Total Assets	$41.9M	↓ 5.88%
Total Liabilities	$20.0M	↓ 1.19%

	Q1 FY24	Q/Q Change
Total Assets	$39.5M	↓ 5.86%
Total Liabilities	$19.4M	↓ 2.84%

	Q2 FY24	Q/Q Change
Total Assets	$36.0M	↓ 8.71%
Total Liabilities	$19.3M	↓ 0.88%

	Q3 FY24	Q/Q Change
Total Assets	$50.9M	↑ 41.43%
Total Liabilities	$34.7M	↑ 80.32%

	FY18	Y/Y Change
Operating Cash Flow	$-2.5M	↓ 45.52%
Investing Cash Flow	$-265.5K	↑ 225.44%
Financing Cash Flow	$9.9M	↓ 16932.07%

	FY19	Y/Y Change
Operating Cash Flow	$-4.6M	↑ 81.29%
Investing Cash Flow	$-29.5K	↓ 88.89%
Financing Cash Flow	$24.0M	↑ 142.22%

	FY20	Y/Y Change
Operating Cash Flow	$-3.5M	↓ 23.93%
Investing Cash Flow	$-70.9K	↑ 140.44%
Financing Cash Flow	$17.3M	↓ 27.85%

	FY21	Y/Y Change
Operating Cash Flow	$-2.9M	↓ 16.11%
Investing Cash Flow	$-1.4M	↑ 1869.91%
Financing Cash Flow	$547.4K	↓ 96.84%

	FY22	Y/Y Change
Operating Cash Flow	$-8.4M	↑ 185.65%
Investing Cash Flow	$-22.1M	↑ 1482.0%
Financing Cash Flow	$220.0K	↓ 59.81%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.9M	↑ 4.6%
Investing Cash Flow	$20.1M	↓ 5866.19%
Financing Cash Flow	$-26.0K	↓ 146.43%

Stereotaxis Technicals Summary

Sell

Neutral

Buy

Stereotaxis is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Stereotaxis Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Stereotaxis Inc	-3.98%	13.61%	24.71%	-63.03%	-52.2%
Intuitive Surgical, Inc.	0.44%	27.24%	63.57%	58.09%	173.59%
Resmed Inc.	-1.4%	15.46%	42.49%	-6.93%	57.19%
Becton, Dickinson And Company	-5.61%	-4.54%	-7.91%	-12.41%	-17.95%
West Pharmaceutical Services Inc	-2.53%	-5.06%	-11.23%	-27.59%	116.82%
Alcon Ag	-7.01%	-6.06%	14.34%	2.68%	52.55%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Stereotaxis Inc	NA	NA	0.0	-0.27	-1.06	-0.29	NA	0.13
Intuitive Surgical, Inc.	87.76	87.76	4.06	6.84	0.16	0.08	NA	43.75
Resmed Inc.	32.57	32.57	1.86	7.71	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	37.72	37.72	1.02	13.11	0.06	0.03	0.02	89.47
West Pharmaceutical Services Inc	47.14	47.14	5.94	6.66	0.18	0.1	0.0	37.96
Alcon Ag	36.67	36.67	3.1	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Stereotaxis Inc	Buy	$186.4M	-52.2%	NA	-85.79%
Intuitive Surgical, Inc.	Buy	$195.9B	173.59%	87.76	28.51%
Resmed Inc.	Buy	$36.0B	57.19%	32.57	23.15%
Becton, Dickinson And Company	Buy	$64.0B	-17.95%	37.72	7.13%
West Pharmaceutical Services Inc	Buy	$23.0B	116.82%	47.14	17.37%
Alcon Ag	Buy	$42.7B	52.55%	36.67	11.89%

About Stereotaxis

stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. these innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. over 100 issued patents support the stereotaxis platform. the core components of stereotaxis’ systems have received regulatory clearance in the united states, european union, japan, canada, china, and elsewhere. for more information, please visit www.stereotaxis.com.

Organization	Stereotaxis
Employees	122
CEO	Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
Industry	Medical Specialties

Management People of Stereotaxis

Name	Title
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.	CEO & Chairman
Ms. Kimberly R. Peery CPA	CFO & Secretary
Mr. Keith Galloway	Vice President of Operations

Important FAQs about investing in Stereotaxis from India :

What is Stereotaxis share price today?

Stereotaxis (STXS) share price today is $2.24.

Can Indians buy Stereotaxis shares?

Yes, Indians can invest in the Stereotaxis (STXS) from India.

With INDmoney, you can buy Stereotaxis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Stereotaxis at zero transaction cost.

How can I buy Stereotaxis shares from India?

It is very easy to buy Stereotaxis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stereotaxis be purchased?

Yes, you can buy fractional shares of Stereotaxis with INDmoney app.

What are the documents required to start investing in Stereotaxis stocks?

To start investing in Stereotaxis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.